Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
The success of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance.
Siemens earnings beat estimates on strong demand for electrification, software
German industrial technology giant Siemens on Thursday posted better-than-expected quarterly operating profit and confirmed its full-year outlook.
Warner Bros. Discovery stock falls as it writes down $9.1 billion, misses estimates
Warner Bros. Discovery reports earnings after the bell.
Disney falls on concerns about its theme park business. Here’s why we’d buy the stock
The entertainment giant delivered the streaming profits we've waited a long time to see.
Here’s why Eli Lilly is down heading into earnings — and how we plan to play it
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Sunrun sees market opportunity after SunPower files for bankruptcy, company’s shares surge
Sunrun posted a surprise profit and sees opportunity to gain market share.
CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave
CVS said higher medical costs are weighing on its insurance business, and announced Aetna President Brian Kane will step down.
Sony rules out renewing offer for Paramount, says it wouldn’t fit strategy
Hiroki Totoki, Sony's chief financial officer, said the tech giant has no plans to submit a revised offer for Paramount.
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook
Novo Nordisk on Wednesday announced its second quarter earnings for 2024.